Daniel holds a Ph.D. in Pharmaceutical Chemistry from Ohio State University, Columbus, and brings extensive expertise in techniques such as HPLC/UPLC, LC-MS, GC, UV-Vis, FTIR, CD spectroscopy, NMR and capillary electrophoresis. He has led cross-functional efforts to develop robust analytical methods for generic drugs, gene therapies, protein drugs and nanoparticles, ensuring compliance with FDA and ICH guidelines. Daniel has also published more than 15 peer-reviewed papers and conference abstracts, acting as a manuscript reviewer for multiple notable pharmaceutical journals such as Molecular Therapy and AAPS.

Known for a data-driven approach and meticulous attention to quality, Daniel is passionate about solving complex analytical challenges and optimizing laboratory workflows. He thrives in collaborative environments and is committed to advancing life-saving therapies through rigorous scientific integrity and innovation.